Healthcare Realty is a REIT that owns or holds joint-venture stakes in 560 US outpatient medical buildings, 73% on or next to hospital campuses, leased to health systems and physician groups.
Latest research: initiation, Nov 13, 2026 · Market value $6,646m
HRHoldTarget $17.38−5% expected
Our view, Nov 13, 2026
Healthcare Realty’s clinics are filling up, but its cash grows slowly, so we see downside
Healthcare Realty owns 560 outpatient medical buildings, mostly beside hospitals, and doctors renew 88% of their suites. But refits and commissions take about 16% of property income, so cash per share grows only 3.0% a year, like cheaper landlords.
What each case is worth today
Circle size shows how likely we think each case is. The target weights all three and adds 12 months of expected return. Source: Penmark Research.
For FY26E we forecast earnings per share of $1.67, against analysts’ $1.65. For FY27E we forecast earnings per share of $1.75, against analysts’ $1.69.
Our earnings per share forecasts against analysts’
Our estimateAnalysts’ forecast
Earnings per share as the report gives them. Analysts’ forecast is the consensus figure in the report. Source: Penmark Research estimates.
Two Fed hikes take the 10-year Treasury yield above 5.3%: −$1.01 a share.
TI/LC stays at 17.5% of NOI or more, as in 3Q26: −$0.40 a share; hospital margin pressure slowing FY27E same-store growth to 3.0%: −$0.30 a share.
Upside risk: a 50bp fall in the 10-year Treasury yield adds $1.15 a share.
What bulls get right. Private buyers pay more for these buildings: our net asset value is $21.68 a share. A sale of the company near that value would make the shares a Buy.
Dates to watch
The 10-year yield is 4.98%; a 50bp move is about −$1.01 or +$1.15 a share.
We expect $1.75 of funds from operations a share and $114.6m of refits; analysts expect $1.69.
More than $100m of sales under letter of intent, at prices near a 5.5% yield.
The 3.75% notes move onto a term loan at about 4.8% until May 2029.
Is Healthcare Realty Trust stock a buy, hold or sell?
Penmark Research rates Healthcare Realty Trust (HR) Hold, with a 12-month price target of $17.38, -10% from the $19.35 share price at our latest report. We expect a total return of between −10% and +10% over the next 12 months.
What is the HR price target?
Our 12-month price target for Healthcare Realty Trust is $17.38, set in our initiation of Nov 13, 2026. Our bear case values the shares at $14.13 and our bull case at $19.73. The target comes from the probability-weighted value of our bull, base and bear cases.
Will Healthcare Realty Trust stock go up?
Our Healthcare Realty Trust stock forecast is a 12-month price target of $17.38, -10% from the $19.35 share price at our latest report, which is why we rate it Hold. Our bear case puts the shares at $14.13 (-27%) and our bull case at $19.73 (+2%). No forecast is certain; the main risks are below.
What does Healthcare Realty Trust do?
Healthcare Realty is a REIT that owns or holds joint-venture stakes in 560 US outpatient medical buildings, 73% on or next to hospital campuses, leased to health systems and physician groups.
What are the main risks to Healthcare Realty Trust stock?
Two Fed hikes take the 10-year Treasury yield above 5.3%: −$1.01 a share.
TI/LC stays at 17.5% of NOI or more, as in 3Q26: −$0.40 a share; hospital margin pressure slowing FY27E same-store growth to 3.0%: −$0.30 a share.
Upside risk: a 50bp fall in the 10-year Treasury yield adds $1.15 a share.
What is Penmark’s latest research on Healthcare Realty Trust?
Our latest report is our initiation of Nov 13, 2026, “Hold on −5.0% total return: $17.38 target as TI/LC and debt resets cap FAD growth”. We initiate on Healthcare Realty at Hold with a $17.38 target, implying −5.0% total return (−10.2% price return), with Low conviction. Campus leasing lifts FY27E Normalised FFO to $1.75 a share, 3.8% above the $1.69 consensus, but TI, leasing commissions and building capex take about 16% of NOI, leaving FY27E FAD at…